Antibodies specific for oncofetal fibronectin

Chemistry: molecular biology and microbiology – Spore forming or isolating process

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 72, 53038825, 5303871, 5303881, 530380, C12N 512, C07K 1618, C07K 1478, G01N 3353

Patent

active

055232299

ABSTRACT:
Immunologic binding partners which specifically bind to oncofetal fibronectin but not normal adult fibronectin or blood plasma fibronectin and methods of diagnosing and treating oncogenesis and reproductive abnormalities employing the same.

REFERENCES:
patent: 4894326 (1990-01-01), Matsuura et al.
Matsuura et al., "The Oncofetal Structure of Human Fibronectin Defined by Monoclonal Antibody FDC-6", J. Biol. Chem. 263: 3314-3322 (1988).
Matsuura et al., "An .alpha.-N-Acetylgalactosaminylation at the Threonine Residue of a Defined Peptide Sequence Creates the Oncofetal Peptide Epitope in Human Fibronectin", J. Biol. Chem. 264: 10472-10476 (1989).
Matsuura and Hakomori, "The Oncofetal Domain of Fibronectin Defined by Monoclonal Antibody FDC-6: Its Presence in Fibronectins from Fetal and Tumor Tissues and Its Absence in those from Normal Adult Tissues and Plasma", Proc. Natl. Acad. Sci. USA 82: 6517-6521 (1985).
Mandel, V. et al, APMIS, 100(9):817-826, 1992.
Loridon-Rosa, B. et al., Cancer Res., 50(5):1608-1612, 1990.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies specific for oncofetal fibronectin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies specific for oncofetal fibronectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies specific for oncofetal fibronectin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-382769

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.